Pharm. Res.

A Cell-Free Approach Based on Phospholipid Characterization for Determination of the Cell Specific Unbound Drug Fraction (f u,cell).

Treyer A, Walday S, Boriss H, Matsson P, Artursson P

Pharm. Res. 36 (12) 178 [2019-11-07; online 2019-11-07]

Drug Discovery and Development (DDD) [Technology development]

In vitro and in silico strategies to identify OATP1B1 inhibitors and predict clinical drug-drug interactions.

Karlgren M, Ahlin G, Bergström CA, ..., Palm J, Artursson P

Pharm. Res. 29 (2) 411-426 [2012-02-00; online 2011-08-23]

Chemical Biology Consortium Sweden (CBCS) [Technology development]